<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Biotechnology on FinanClub</title>
    <link>https://finan.club/tags/biotechnology/</link>
    <description>Recent content in Biotechnology on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Apr 2024 09:02:28 +0000</lastBuildDate><atom:link href="https://finan.club/tags/biotechnology/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>GERN</title>
      <link>https://finan.club/us/gern/</link>
      <pubDate>Mon, 15 Apr 2024 09:02:28 +0000</pubDate>
      
      <guid>https://finan.club/us/gern/</guid>
      <description>score:82
Chances: Geron Corporation&amp;rsquo;s pipeline candidate, imetelstat, received FDA Committee backing for the treatment of transfusion-dependent anemia in adult patients with low-to-intermediate-1 risk myelodysplastic syndromes, indicating potential for successful drug approval and market adoption. Risks: The company recently announced an underwritten offering of its common stock and pre-funded warrants, which may dilute existing shareholders&amp;rsquo; ownership and impact stock performance in the short term.</description>
    </item>
    
    <item>
      <title>SANA</title>
      <link>https://finan.club/us/sana/</link>
      <pubDate>Sat, 02 Mar 2024 09:02:41 +0000</pubDate>
      
      <guid>https://finan.club/us/sana/</guid>
      <description>score:46
Chances: Sana Biotechnology has successfully cleared IND for B-cell mediated autoimmune diseases with initial clinical data expected in 2024 Early data from ongoing ARDENT trial suggests the ability to dose safely, demonstrate the desired immune evasion profile, and early clinical efficacy Risks: Markets are awaiting the latest inflation numbers and the debate regarding soft vs hard landing is expected to persist on Wall Street High institutional ownership implies Sana Biotechnology&amp;rsquo;s stock price is sensitive to their decisions Score:46 chances characters count - risks characters count = 46</description>
    </item>
    
  </channel>
</rss>
